U.S. stock indexes drifted lower following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies

When the healthcare giant reports earnings Thursday morning, investors will be looking to see if Brian Thompson’s death and the public outcry over denials are prompting any changes at the company.

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target

The relatively modest moves for stocks came a day after they shot higher on hopes that an encouraging report on inflation may convince the Federal Reserve to deliver more cuts to interest rates this year. Treasury yields were also more placid in the bond market following mixed economic reports on Thursday..

The selloff in UnitedHealth's stock can be blamed for Dow futures falling, while S&P 500 and Nasdaq 100 futures are rising. The health giant's stock was sinking 3.2% in recent premarket trading, after

U.S. stocks were trading mostly higher after the opening bell on Thursday following the latest corporate earnings reports and another batch of economic data. The Nasdaq was leading stocks higher as tech stocks tried to extend Wednesday's bounce to a second day.

Dow, S&P 500, and Nasdaq futures are falling in premarket trading Monday as the stock market considers a lack of Fed rate cuts in the coming year.

NEW YORK — U.S. stock indexes drifted lower Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies.

That prompted Andrew Witty, the chief executive of all of UnitedHealth (UNH), to write ... be helpful to us on the outside looking in," Morgan Stanley analyst Erin Wright wrote.

J.P. Morgan Self-Directed Investing charges no commissions and offers a highly integrated app, which makes it a solid choice for individuals who want to trade their own investments — especially ...